Total Graphite plc (TGR), the specialist flake graphite company developing an integrated graphite mine-to-materials supply chain for the global energy transition, announced that, following an advanced stage of the operational
Total Graphite plc (TGR), the specialist flake graphite company developing an integrated graphite mine-to-materials supply chain for the global energy transition, announced that, following an advanced stage of the operational
GENinCode plc (AIM: GENI) has conditionally raised £3.9m in gross proceeds through the issue of 388,145,000 new ordinary shares at 1p each, representing a 47.4pc discount to the closing middle
The biotechnology market has delivered a mixed landscape in 2025, shaped by shifting investor sentiment, ongoing regulatory pressures, and the continued search for differentiated clinical assets. Against this backdrop several
The biotechnology market has delivered a mixed landscape in 2025, shaped by shifting investor sentiment, ongoing regulatory pressures, and the continued search for differentiated clinical assets. Against this backdrop several
FTSE 100 ends session near all-time peak, closing up 59.65 points at 9,897, a gain of 0.6% that leaves the index edging closer to its record high of 9,930 set
GENinCode Plc has entered into a commercial agreement with Sohin Genetics in Mexico to distribute its CARDIO inCode-Score® Polygenic Risk Score test, which is designed to help predict and prevent
The Times: The headline rate of inflation fell more than expected in November to a 10-month low – increasing expectations that the Bank of England will cut interest rates tomorrow. The
Amazing AI plc (AQSE: AAI) AAI is a global fintech group with a Digital Asset Treasury Policy that provides online consumer loans and AI finance-related services. AAI announces that a circular
GENinCode Plc (AIM: GENI) shares climbed 33% after the company announced a major collaboration with Thermo Fisher Scientific to commercialise its CARDIO inCode-Score® Polygenic Risk Score test for predicting and
GENinCode PLC (AIM: GENI) jumped 32% to 2.84p in early trading after securing approval from the New York State Department of Health (NYSDOH) for its CARDIO inCode-Score test, which assesses
Solvonis Therapeutics plc (SVNS), an emerging biopharmaceutical company developing novel medicines for high-burden central nervous system (CNS) disorders, announced that its novel AI-discovered compound, SVN-015, targeting methamphetamine and cocaine use disorders,
The Telegraph: Co-op unveils £206m hit from cyber attack. IT shutdown led to data from retailers’ 6.5 million members being stolen